课题基金 / 基金详情

CAREER: High-throughput Imaging of Drug Response in Tumor Organoids

CAREER: High-throughput Imaging of Drug Response in Tumor Organoids
职业:肿瘤类器官药物反应的高通量成像
批准号:
1554027
负责人:
Melissa Skala
金额:
$50.95万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-05-01 至 2016-07-31

项目摘要

项目成果

Melissa Skala的其他基金

相似基金

相关文献

中文摘要
翻译
Scala,Melissa提案:1554027该提案的重点是开发一种高通量成像技术,以测量与其自然环境中的细胞一起培养的肿瘤细胞的药物反应和细胞代谢。获得的数据将用于预测肿瘤对多种药物的反应,提供可用于优化个别癌症患者药物治疗的信息。该教育计划包括一门新的光学成像本科课程,重点是针对初中生和女孩的推广活动。将创建干涉光片傅立叶荧光寿命成像显微镜(ILS-FP-FLIM),并通过成像在小鼠模型中培养的人乳腺癌细胞中的NADH和FAD辅酶来获得信息。这将被用来预测肿瘤对多种药物的反应,提供可用于为个别癌症患者优化药物治疗的信息。
英文摘要
ABSTRACTPI: Scala, Melissa Proposal: 1554027The proposal focuses on developing a high-throughput imaging technology to measure drug response and cellular metabolism in tumor cells cultured with cells in their native environment. The data obtained will be used to predict tumor response to multiple drugs, providing information that can be used to optimize drug treatment for the individual cancer patient. The Educational Plan, which includes a new undergraduate course in optical imaging, has a strong emphasis on outreach activities directed at middle and high school students and girls.Interference light sheet Fourier Fluorescence lifetime imaging microscopy (iLS-FP-FLIM) will be created and information obtained by imaging NADH and FAD coenzymes in human breast cancer cells grown in a mouse model. This will be used to predict tumor response to multiple drugs, providing information that can be used to optimize drug treatment for the individual cancer patient.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I-Corps: A label-free, autofluorescence lifetime flow cytometer for in-line monitoring of T cell function
  • 批准号:
    2319225
  • 项目类别:
    Standard Grant
  • 资助金额:
    $5.0万
  • 财政年份:
    2023
  • 负责人:
    Melissa Skala
  • 依托单位:
CAREER: High-throughput Imaging of Drug Response in Tumor Organoids
国内基金
海外基金
转录因子DNA结合谱绘制新方法及其应用研究
  • 批准号:
    61171030
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    王进科
  • 依托单位: